Charles is a Clinical Research Fellow at the Department of Psychosis Studies, Instituteof Psychiatry, Psychology and Neuroscience (IoPPN), King’s College London, wherehe works with the Translational Neuroscience and Psychiatry Research Group.Charles’ research interests focus on how translational approaches can inform realworldclinical practice; particularly, how an improved understanding of theneurobiological mechanisms underlying psychotic disorders can help develop betternovel treatments. He is currently working on a trial investigating the efficacy of oralcannabidiol in people at clinical high risk for psychosis, alongside other projectsexploring risk factors for psychotic relapse.

Charles is a medical doctor and current core psychiatry trainee at South London andMaudsley NHS Foundation Trust. Prior to this, Charles completed an undergraduateBSc (Hons) in Molecular Biology at Cardiff University, postgraduate medical training(MBBS) at the University of East Anglia and an MSc in Psychiatric Research at theIoPPN, King’s College London.

Charles has received numerous prizes and awards; the most notable of these beingthe Sir Robin Murray Prize for Academic Excellence and Professor Shitij Kapur Prizefor Innovation. Charles has also written articles for medical publications, includingthe British Journal of Psychiatry.

Research Interest

• Experimental medicine
• Early intervention in psychosis
• Neurosciences

Research Groups

• Translational Neuroscience & Psychiatry Lab (PI: Professor Sagnik Bhattacharyya)
• Department of Psychosis Studies